Literature DB >> 6386232

N-terminal procollagen peptide and beta 2-microglobulin in synovial fluids from inflammatory and non-inflammatory joint diseases.

A M Gressner, H H Neu.   

Abstract

The concentrations of NH2-terminal procollagen peptide were determined radioimmunologically in synovial fluids from inflammatory and non-inflammatory joint diseases. The mean concentrations +/- SD were 1.39 +/- 0.77 and 1.13 +/- 0.63 mg/l and, hence, did not reveal significant differences. Compared with serum, peptide levels in synovial fluids are 10(3) times higher. No statistical correlation was found between procollagen peptide levels and the concentrations of beta 2-microglobulin, a suggested parameter of disease activity, and other established indicators (total protein, total and differential cell count) of inflammatory activity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6386232     DOI: 10.1016/0009-8981(84)90016-0

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Serum aminoterminal type III procollagen peptide in inflammatory and degenerative rheumatic disorders.

Authors:  K Hørslev-Petersen; K D Bentsen; P Junker; F K Mathiesen; T M Hansen; I Lorenzen
Journal:  Clin Rheumatol       Date:  1988-03       Impact factor: 2.980

2.  Differential patterns of PMN-elastase and type III procollagen peptide in knee joint effusions due to acute and chronic sports injuries.

Authors:  K A Riel; M Jochum; P Bernett; H Fritz
Journal:  Klin Wochenschr       Date:  1991-11-15

3.  The aminoterminal-type-III procollagen peptide and proteoglycans in serum and synovial fluid of patients with rheumatoid arthritis or reactive arthritis.

Authors:  K Hørslev-Petersen; T Saxne; D Haar; B S Thomsen; K D Bentsen; P Junker; I Lorenzen
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

4.  Application of markers of collagen metabolism in serum and synovial fluid for assessment of disease process in patients with rheumatoid arthritis.

Authors:  M Hakala; S Aman; R Luukkainen; L Risteli; M Kauppi; P Nieminen; J Risteli
Journal:  Ann Rheum Dis       Date:  1995-11       Impact factor: 19.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.